Objective: Oxycodone, a semi-synthetic thebaine derivative opioid, is commonly used for treating moderate to severe pain. The aim of this study was to compare the efficacy and side effects of oxycodone and fentanyl used for treating postoperative pain with intravenous patient-controlled analgesia (IV-PCA) after laparoscopic gynecologic surgery. Methods: A total of 122 patients were randomized to receive postoperative pain treatment with either oxycodone (n= 62, group O) or fentanyl (n= 60, group F). Patients received 7.5 mg oxycodone and 150 mcg fentanyl with ketorolac 30 mg at the end of anesthesia, and then continued with IV-PCA (conversion dose ratio, 50:1) for 48 hours postoperatively. A blinded observer assessed postoperative pain based on a numerical rating scale, postoperative nausea and vomiting and other side effects, infused PCA dose, patient satisfaction, and sedation level. Results: No significant differences were observed in patient satisfaction according to the analgesic used during the 48 hours postoperative period. Conclusion: Oxycodone showed similar efficacy for pain relief compared to fentanyl when used at a conversion dose ratio of 50:1. Therefore, oxycodone may be useful as an alternative to fentanyl for IV-PCA after laparoscopic gynecologic surgery.
INTRODUCTION
Recent advances in surgery and anesthesia have led to a significant reduction in severe postoperative complications. However, patients have a higher need for comfortable anesthesia management with minimal postoperative side effects. Among common symptoms occurring after surgery, postoperative nausea and vomiting (PONV, 49%) and postoperative pain (27%) are the two most important concerns for patients recovering after surgery [1] .
Various methods have been used to control postoperative pain; among them, intravenous patient-controlled analgesia (IV-PCA) has been commonly applied because it has high pain relief efficacy with minimal side effects [2] ; it has been reported that IV-PCA is associated with higher analgesic efficacy and patient satisfaction levels than conventional methods [3] .
In general, laparoscopic surgery has several advantages including decreased postoperative pain, faster recovery, and better cos-metic effects compared to laparotomy [4] . However, there have been many cases of moderate pain after minor laparoscopic surgery due to minimal use of analgesics [5] . In addition, patients undergoing laparoscopic gynecologic surgery are at high risk of PONV and are more likely to complain of pain than those undergoing general surgery; PCA may be interrupted due to PONV. Therefore, when IV-PCA is used after laparoscopic gynecologic surgery (which is relatively minor), it is important to select appropriate analgesic agents and adjust the dose and lockout interval to obtain satisfactory analgesic effects while reducing side effects such as PONV.
In Korea, fentanyl is the opiate most commonly used as an analgesic agent for IV-PCA after surgery. In 2013, IV-dihydrohydroxycodeinone (oxycodone) was approved for IV-PCA by the Ministry of Food and Drug Safety and released to the market [6] . Oxycodone is a semisynthetic analgesic opioid made from thebaine (derived from poppy), which acts on μ-opioid receptors to relieve mild to severe pain [7] . If oxycodone is used in excess or in opioidsensitive patients, there is a risk of respiratory depression, bradycardia, apnea, hypotension, circulatory insufficiency, respiratory arrest, and death, as well as minor side effects such as PONV [6] .
Therefore, it is important to establish a safe dose for the direct conversion factor of fentanyl and oxycodone, which are the most commonly used analgesic agents in IV-PCA.
When IV oxycodone was first introduced, a conversion dose ratio of 1:100 between fentanyl and oxycodone was recommended.
However, several studies have instead recommended a conversion ratio of 1:75 [8, 9] , while others recommended a ratio of 1:60 [10, 11] .
When using a conversion dose ratio of 1:60, the analgesic effect was similar but the PCA consumption of oxycodone was less than that of fentanyl [10] ; at a ratio of 1:60, there was a difference in the analgesic effect between the two groups [11] . Therefore, we hypothesized that the conversion dose ratio between fentanyl and oxycodone could be decreased to 1:50 in this study.
The purpose of this study was to compare the analgesic effect, PCA usage, side effects (including PONV), and patient satisfaction, at a 1:50 conversion dose ratio, between fentanyl and oxycodone, which are the analgesic agents most commonly used for IV-PCA after laparoscopic gynecologic surgery at Soonchunhyang University Cheonan Hospital.
MATERIALS AND METHODS
This study was approved by the Institutional Review Board of Soonchunhyang University Cheonan Hospital (IRB approval no.,
2016-06-013) and registered on the International Clinical Trials
Registry Platform (http://cris.nih.go.kr, KCT 0002275). A total of 130 adult patients aged 18 to 65 years, with an American Society of Anesthesiologists (ASA) physical status of 1 or 2 and who had requested postoperative IV-PCA for laparoscopic gynecologic surgery scheduled at our hospital, were included in this study. Patients with a history of bleeding, hepatitis, or renal failure; those with habitual sedative or other drug use; those with psychiatric disease; and those who were inappropriate candidates for IV-PCA were excluded.
On the day before surgery, patients were informed of the purpose of the study, and the PCA method, numerical rating scale (NRS), and possible side effects of the two forms of IV-PCA were discussed.
All patients included in the study provided written informed consent, after which they were randomly allocated to either the fen-tanyl (fentanyl citrate; Guju, Seoul, Korea) group (group F, n = 60) or the oxycodone (OxyNorm; Mundipharma, Seoul, Korea) group (group O, n = 62). Group allocation was performed by a blinded observer according to a computer-generated randomization code.
On the morning before the operation, vascular access was secured using an 18G needle. Patients were transported to the operation room without pre-anesthetic medication. Upon arrival, they were connected to an electrocardiograph, a non-invasive blood pressure monitor, and a pulse oximeter. Anesthesia was induced by IV in- The required number of patients was determined based on a previous study [12] . The primary endpoint was the NRS score at 
RESULTS
A total of 130 patients were screened, among whom 125 were enrolled in the study, were divided randomly into two groups. Of the study patients, two in group F and four in group O were excluded from the study. The data of the remaining 122 patients were analyzed, with 60 patients in group F and 62 patients in group O (Fig. 1 ).
There were no significant differences between the two groups in age, height, body weight, operation time, anesthesia time, ASA physical status, amount of fluid injected during surgery, motionsickness, or smoking history (Table 1) . Group O showed a significantly lower level of PCA consumption than Group F at 0-48 hours after surgery (Fig. 2) .
In terms of pain at rest based on the NRS, group O showed a significantly lower level upon arrival to the PACU, but there was no significant difference between the two groups at 30 minutes, 2 hours, 8 hours, 24 hours, or 48 hours after surgery (Fig. 3 ). For coughing, the two groups did not show any significant difference on the NRS (Fig. 4 ).
There was no significant difference in terms of PONV incidence between the two groups ( Table 2 ). In addition, the rate of additional use of rescue analgesics and antiemetics was not significantly different between the two groups (Table 3 ). There was no signifi- (Table 4 ). There was no significant difference in sedation scores between the two groups ( Fig. 5 ). Finally, there was no significant difference in patient satisfaction measured at 2 and 48 hours after surgery between the two groups (Table 5 ).
DISCUSSION
Opioids, which are commonly used for IV-PCA, are full μ-receptor binding agonists that do not have an analgesic ceiling effect for pain control. However, there may be a clinical ceiling effect due to side effects including sedation, and especially respiratory depression [2] . Fentanyl has desirable properties as an IV-PCA drug, including very high lipid solubility, a rapid onset of analgesic effect (within 30 seconds) with a peak at 5 minutes after administration, rapid and widespread redistribution inside the body, and no production of active metabolites that can cause respiratory depression [2, 13] .
Oxycodone is a semi-synthetic opioid developed in 1916 in Germany with the goal of improving the performance of opioids [7] .
In addition, it has structural similarity to morphine, which is the standard opioid used worldwide, and shows an analgesic effect against a combination of somatic and visceral pain after surgery at a conversion dose ratio of 1:1 [14] . Since oxycodone is metabolized in the cytochrome P450 enzyme system in the liver and acts on the μ-opioid receptor, it can cause side effects such as nausea, constipation, drowsiness, vomiting, pruritus, and dizziness, similar to other opioids [7] . Oxycodone should be diluted to a concentration of 1 mg/mL when used for IV-PCA; the loading dose of 2 mg should be administered to stabilize pain, after which 1 mg is administered as necessary without background infusion. However, Choi [6] reported that because the administration of 2 mg/kg reached a plasma concentration below the MEAC, injection at a concentration of 0.1 mg/kg may be more appropriate, and also noted that background infusion at a rate of 1 mL/hr could reach the MEAC most rapidly.
In this study, a loading dose of 7.5 mg (which is higher than 0.1 mg per kg) was administered because the results of our previous study showed that when a 7.5 mg bolus dose of oxycodone was injected after surgery we achieved an average NRS of 30 or higher 30 minutes after surgery [17] . Thus, the same amount, or a higher dose, of oxycodone should be administered. The loading dose of fentanyl was 150 mcg with a conversion dose of 1:50, and the NRS immediately after surgery was below 30, which was lower than that for oxycodone, indicative of a satisfactory analgesic effect (Fig. 3 ). Although there was no significant difference between the two groups 2 or more hours after surgery, the fentanyl-based IV-PCA showed a higher level of NRS than the oxycodone-based IV-PCA.
These results were in contrast with previous studies showing that a conversion dose of 1:75 between fentanyl and oxycodone may be appropriate [8, 9] . In previous studies, only the bolus dose was given for IV-PCA without continuous background infusion. However, when administration is via IV-PCA with continuous background infusion for several days, it is important to consider differences in pharmacokinetics between the two agents. Oxycodone has an onset time of analgesia of 2-3 minutes, which is as fast as fentanyl, but with a slightly longer duration of action (t1/2: 4 hours 52 minutes versus 3 hours 39 minutes). However, after a single dose of fentanyl was injected, the analgesic effect showed a shorter duration due to redistribution [9] . Therefore, there was no significant difference at the 1:50 conversion dose between fentanyl and oxycodone, but the NRS score started to decline from 2 hours after the operation when the effect of the bolus loading dose disappeared.
Kawamata et al. [18] reported an experimental incision model where primary hyperalgesia caused by sensitization of the primary afferent nociceptors due to incision started to decrease within 2 hours after incision, whereas secondary hyperalgesia, which causes pain around the incised area due to central hypersensitization started to decrease within 6 hours. This study showed a significant decrease in NRS scores starting from 2 hours after surgery, which was due to a very small incision size. Therefore, pain control is the most important priority until 2 hours after surgery, but as the severity of pain was significantly decreased at 2 hours after surgery, other side effects including PONV should be considered. In this study, two patients discontinued PCA due to PONV.
Eberhart et al. [1] reported that PONV (49%) was a more important patient concern than pain (27%), which was common after surgery. PONV can increase medical costs and morbidity, and delay recovery and discharge; in severe cases, it can lead to readmission [19] . Risk factors for PONV include female gender, nonsmoking, a medical history of PONV, and use of opioids during and after surgery. It has been reported that if a patient has one risk factor, the incidence rate of PONV is 21%; with two risk factors, it rises to 39%; with three high risk factors, the incidence is 61% and with four it is 79% [20] . Prophylactic anti-emetics are recommended for high-risk patients, and we administered dexamethasone 5 mg IV as a prophylactic anti-emetic agent at the beginning of the operation and added ramosetron 0.3 mg after surgery. In this study, because we administered prophylactic anti-emetics and used an appropriate opioid, both groups showed a PONV incidence rate of less than 15%, although they were high-risk patients ( Table 2) .
When the patients were surveyed based on patient satisfaction after surgery, there was no significant difference at 2 or 48 hours after surgery between the groups (Table 5) ; they showed a similar analgesic effect and side effects at a 1:50 conversion dose of fentanyl and oxycodone.
The limitations of this study were as follows: first, although the Ambix Anapa, a PCA machine used at our hospital, has several advantages, i.e., it is small, lightweight, and easy to carry, because background continuous infusion at a rate 2 mL/hr and a bolus dose of 0.5 mL with a lockout interval of 15 minutes were established, patients were not guaranteed autonomy in terms of pain control. Also, there was no way to confirm the delivery attempt ratio and it was not possible to calculate an the equianalgesic dose of fentanyl and oxycodone accurately. Second, patient age is an important factor affecting the pharmacokinetics of oxycodone, and patients aged 70 years or more are reported to have a relatively higher average oxycodone exposure of 40%-80% compared to young adults [21] . As this targeted patients aged 65 years or less, more studies on patients aged 70 years or more are required. Last, the pain threshold may have differed among the patients, but no preliminary study was performed to explore this.
In conclusion, oxycodone showed similar effects, in terms of pain relief and side effects, compared to fentanyl when used at a conversion dose ratio of 50:1 after laparoscopic gynecologic surgery. Therefore, oxycodone may be useful as an alternative to fentanyl for IV-PCA after minor laparoscopic surgery.
